Current insight into klebsiella infection in children

Abstract

Klebsiella pneumoniae is an important causative agent of nosocomial and community-acquired infections in children. The relevance of Klebsiella infection has increased in recent years due to the spread of multiresistant and hypervirulent strains that can cause invasive forms of infection (sepsis, meningitis, liver abscess, etc.). Strains of Kl. pneumoniae, producing extended-spectrum β-lactamase (ESBL), as well as carbapenem-resistant strains, are the cause of nosocomial outbreaks with high mortality. The choice of antibacterial drugs for the treatment of invasive forms of infection is limited and depends on the spectrum of sensitivity to antimicrobial drugs of Klebsiella clinical isolates circulating in the hospital and the age of the child. Due to the high rate of ESBL production, carbapenems are the drugs of choice in the empirical therapy of invasive forms of infection.